BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18949774)

  • 1. A sweet summer for drug-eluting stents in patients with diabetes mellitus.
    Costa MA
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):610-1. PubMed ID: 18949774
    [No Abstract]   [Full Text] [Related]  

  • 2. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug eluting stents in AMI: keep the data coming.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
    [No Abstract]   [Full Text] [Related]  

  • 4. Multivessel disease in diabetics: does DES level the field?
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):881-2. PubMed ID: 19455651
    [No Abstract]   [Full Text] [Related]  

  • 5. Native vessel PCI in the diabetic: DES whenever feasible.
    Hillegass W
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):608-9. PubMed ID: 18949773
    [No Abstract]   [Full Text] [Related]  

  • 6. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
    Byrne RA; Kastrati A
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of clinically driven target lesion revascularization from bare-metal stents to drug-eluting stents.
    Park SJ
    Catheter Cardiovasc Interv; 2007 Aug; 70(2):184. PubMed ID: 17630660
    [No Abstract]   [Full Text] [Related]  

  • 9. "Stick the landing," for optimal ostial placement of stents.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 May; 73(6):769-70. PubMed ID: 19367630
    [No Abstract]   [Full Text] [Related]  

  • 10. Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?
    Brilakis ES; Berger PB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):815-8. PubMed ID: 19006238
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.
    Cohen M
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):579-97. PubMed ID: 19472347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Anti-healing" versus "pro-healing".
    Seth DA
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
    [No Abstract]   [Full Text] [Related]  

  • 13. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
    Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M;
    EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063
    [No Abstract]   [Full Text] [Related]  

  • 14. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 15. The titanium nitride oxide coated stent.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):288-90. PubMed ID: 20665879
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 17. Long term safety: not only a drug eluting stents issue.
    Fineschi M; Zacà V; Gori T
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1051; author reply 1052. PubMed ID: 18044789
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A; Curzen N
    Thromb Haemost; 2009 Jan; 101(1):23-30. PubMed ID: 19132185
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical presentation of patients with late target lesion revascularization.
    Kaneda H
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):749. PubMed ID: 18942148
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.